Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Sirolimus Conversion on Atherosclerosis in Renal Transplant
NCT00311311Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Apr 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sirolimus in atherosclerosis, sponsored by Pfizer. Started Apr 2006; status: terminated.
02
Drugs
sirolimus
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00311311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311311.